Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To systematically review the clinical effects, efficacy and safety of pharmacological augmentation for clozapine in treatment-resistant schizoaffective disorder.
Author supplied keywords
- adverse drug reaction
- automutilation
- blood dyscrasia
- cardiovascular disease
- central nervous system disease
- clozapine
- depression
- drug efficacy
- drug safety
- extrapyramidal symptom
- gastrointestinal symptom
- health care utilization
- health status
- human
- manic psychosis
- mental health
- metabolic disorder
- myocarditis
- negative syndrome
- outcome assessment
- patient satisfaction
- positive syndrome
- quality of life
- randomized controlled trial (topic)
- review
- risk assessment
- schizoaffective psychosis
- suicide
- systematic review
- treatment resistant schizoaffective disorder
Cite
CITATION STYLE
APA
J., L., J., T., & J.H., M. (2016). Clozapine augmentation for treatment-resistant schizoaffective disorder. Cochrane Database of Systematic Reviews, 2016(3). Retrieved from http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L609168956 http://dx.doi.org/10.1002/14651858.CD012104
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free